Aldeyra Therapeutics Stock (NASDAQ: ALDX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 586.579K |
Day Range | - - - |
52 Wk Range | 1.420 - 11.970 |
Market Cap | $234.093M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 4.16% |
Days to Cover | 5.87 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aldeyra Therapeutics (NASDAQ: ALDX) through any online brokerage.
Other companies in Aldeyra Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Galectin Therapeutics (NASDAQ:GALT), Inovio Pharmaceuticals (NASDAQ:INO) and Century Therapeutics (NASDAQ:IPSC).
The latest price target for Aldeyra Therapeutics (NASDAQ: ALDX) was reported by Oppenheimer on Wednesday, April 3, 2024. The analyst firm set a price target for 10.00 expecting ALDX to rise to within 12 months (a possible 153.81% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Aldeyra Therapeutics (NASDAQ: ALDX) is $3.94 last updated April 25, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Aldeyra Therapeutics.
Aldeyra Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Aldeyra Therapeutics.
Aldeyra Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.